Bifogade filer
BONESUPPORT launches next generation of CERAMENT® G
Kurs
+5,54%
Likviditet
35,5 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-10-22 | 08:00 | Kvartalsrapport 2026-Q3 |
| 2026-07-16 | 08:00 | Kvartalsrapport 2026-Q2 |
| 2026-05-12 | N/A | Årsstämma |
| 2026-04-22 | 08:00 | Kvartalsrapport 2026-Q1 |
| 2026-02-24 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-23 | - | Kvartalsrapport 2025-Q3 |
| 2025-07-15 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-28 | - | X-dag ordinarie utdelning BONEX 0.00 SEK |
| 2025-05-27 | - | Årsstämma |
| 2025-04-24 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-25 | - | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-11 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | - | X-dag ordinarie utdelning BONEX 0.00 SEK |
| 2024-05-16 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-13 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-19 | - | X-dag ordinarie utdelning BONEX 0.00 SEK |
| 2023-05-17 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-14 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-20 | - | X-dag ordinarie utdelning BONEX 0.00 SEK |
| 2022-05-19 | - | Årsstämma |
| 2022-05-04 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-15 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-21 | - | X-dag ordinarie utdelning BONEX 0.00 SEK |
| 2021-05-20 | - | Årsstämma |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-17 | - | Bokslutskommuniké 2020 |
| 2020-11-05 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-17 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-20 | - | X-dag ordinarie utdelning BONEX 0.00 SEK |
| 2020-05-19 | - | Årsstämma |
| 2020-05-08 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-26 | - | Bokslutskommuniké 2019 |
| 2019-11-07 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-25 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-15 | - | X-dag ordinarie utdelning BONEX 0.00 SEK |
| 2019-05-14 | - | Årsstämma |
| 2019-05-02 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-27 | - | Bokslutskommuniké 2018 |
| 2018-11-07 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-26 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-23 | - | X-dag ordinarie utdelning BONEX 0.00 SEK |
| 2018-05-22 | - | Årsstämma |
| 2018-05-04 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-20 | - | Bokslutskommuniké 2017 |
| 2017-11-02 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-17 | - | Kvartalsrapport 2017-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announces the launch of the next generation of the company’s breakthrough antibiotic-eluting bone graft substitute, CERAMENT G. Improvements to CERAMENT G have been made to increase ease of use and to reduce environmental impact.
The same composition, mechanism of action, and clinical results as previous versions of CERAMENT G apply, but all components in the kit are now surface sterile. In addition, the shelf life of the product has been extended by one year, to a total of three years. The improvements create a better workflow during surgery leading to increased ease of use and user efficiency. Furthermore, the physical dimensions of the new CERAMENT G kit are 28% smaller than before with packaging material reduced by 35%. The kit improvements were made after extensive consultation with customers.
“Surgical teams value that CERAMENT G comes in an all-in-one kit and this latest update offers greater efficiency in the operating room. At same time, the product’s reduced packaging waste is a step forward in our corporate sustainability objectives,” said Emil Billbäck, CEO of BONESUPPORT.
The next generation of CERAMENT G is first released in Europe and then in other markets over the coming months.
For more information contact:
BONESUPPORT Holding AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70
Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com
Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se
About BONESUPPORT™
BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 329 million in 2022. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.